| Application no. and date | 20753564.2 (espacenet) (Federated) (European Patent Register), 20200716 | | Patent/reg. no. and date | DK/EP 3999181, 20240529 | | Publication date | 20220525 | | Priority no. and date | US 201962875355 P, 20190717 | | EP pub. no. and date |
EP 3999181 20220525 | | Effective date | | | Applicant/owner | Cytokinetics, Inc., 350 Oyster Point Blvd
South San Francisco CA 94080, US | | Applicant ref. no. | | | Inventor | TOM, Norma, 3913 Christian Drive
Belmont, California 94002, US,
ANDERSEN, Denise, PO Box 371608
Montara, California 94037, US | | Representative | | | Opponent | | | IPC Class | A61K 31/4196 (2006.01) , A61P 9/04 (2006.01) , C07D 413/12 (2006.01) | | Title | POLYMORPHS OF (R)-N-(5-(5-ISOPROPYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-METHYL-2H-TETRAZOLE-5-CARBOXAMIDE | | Int. application no. | US2020042390 | | Int. publication no. | WO2021011809 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
